US regulators are considering whether to loosen restrictions on marijuana, in a move aimed at “decriminalizing the drug at the federal level.” The article noted that FDA is reviewing marijuana’s classification as a Schedule 1 drug, citing Douglas Throckmorton, Deputy Director for Regulatory Programs at the FDA, at a congressional hearing. The piece noted that the FDA must “first consult with the National Institute on Drug Abuse and send their recommendation through the Department of Health and Human Services before handing it to the DEA,” citing Throckmorton.
Posted on: Mon, 23 Jun 2014 13:07:00 +0000
Trending Topics
Recently Viewed Topics
© 2015